Posted by Michael Wonder on 09 Aug 2021
Ophthalmologist group wants U.S. Government to push back against Avastin biosimilars
10 August 2021 - The American Academy of Ophthalmology says biosimilar alternatives to Avastin have never been tested in the eye.
The American Academy of Ophthalmology is urging CMS and HHS to prohibit policies pushing ophthalmologists to use biosimilars to Avastin (bevacizumab) in Medicare Advantage and exchange plans.
